Inspire Medical Systems, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4577301090
USD
68.05
8.8 (14.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
269.08
224.50
217.09
201.32
239.72
203.19
195.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
269.08
224.50
217.09
201.32
239.72
203.19
195.88
Raw Material Cost
36.07
31.77
34.67
30.71
35.99
32.40
29.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.12
0.01
0.00
0.00
0.02
0.00
0.00
Selling and Distribution Expenses
161.95
158.87
159.52
144.29
141.51
130.39
132.08
Other Expenses
2.48
2.42
2.62
2.78
3.03
2.61
2.89
Total Expenditure (Excl Depreciation)
222.97
214.86
220.40
202.80
207.83
188.87
190.79
Operating Profit (PBDIT) excl Other Income
46.1
9.6
-3.3000000000000003
-1.5
31.9
14.299999999999999
5.1
Other Income
4.33
3.92
5.03
5.64
4.77
6.01
5.75
Operating Profit (PBDIT)
54.26
17.24
5.13
7.20
39.14
22.18
12.23
Interest
0.12
0.01
0.00
0.00
0.02
0.00
0.00
Exceptional Items
0.00
0.00
-4.05
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
233.01
192.73
182.41
170.61
203.73
170.79
166.04
Depreciation
3.82
3.68
3.41
3.04
2.48
1.85
1.38
Profit Before Tax
50.32
13.55
-2.33
4.16
36.64
20.33
10.85
Tax
-85.77
3.62
1.26
1.17
1.41
1.83
1.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
136.09
9.93
-3.59
2.99
35.22
18.50
9.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
136.09
9.93
-3.59
2.99
35.22
18.50
9.79
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
136.09
9.93
-3.59
2.99
35.22
18.50
9.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
781.16
666.46
677.81
635.74
689.70
696.56
638.07
Earnings per share (EPS)
4.65
0.34
-0.12
0.1
1.15
0.6
0.32
Diluted Earnings per share
4.65
0.34
-0.12
0.1
1.15
0.6
0.32
Operating Profit Margin (Excl OI)
17.14%
4.3%
-1.53%
-0.74%
13.3%
7.05%
2.6%
Gross Profit Margin
20.12%
7.67%
0.5%
3.58%
16.32%
10.91%
6.24%
PAT Margin
50.58%
4.42%
-1.65%
1.49%
14.69%
9.1%
5.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 12.27% vs 24.52% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 286.65% vs 137.84% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 45.06% vs 240.59% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Inspire Medical Systems, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
269.08
1,405.00
-1,135.92
-80.85%
Other Operating Income
0.00
0.00
0.00
Total Operating income
269.08
1,405.00
-1,135.92
-80.85%
Raw Material Cost
36.07
589.00
-552.93
-93.88%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.12
100.00
-99.88
-99.88%
Selling and Distribution Expenses
161.95
564.00
-402.05
-71.29%
Other Expenses
2.48
-0.60
3.08
513.33%
Total Expenditure (Excl Depreciation)
222.97
1,247.00
-1,024.03
-82.12%
Operating Profit (PBDIT) excl Other Income
46.11
158.00
-111.89
-70.82%
Other Income
4.33
5.00
-0.67
-13.40%
Operating Profit (PBDIT)
54.26
262.00
-207.74
-79.29%
Interest
0.12
100.00
-99.88
-99.88%
Exceptional Items
0.00
-50.00
50.00
100.00%
Gross Profit (PBDT)
233.01
816.00
-582.99
-71.44%
Depreciation
3.82
99.00
-95.18
-96.14%
Profit Before Tax
50.32
13.00
37.32
287.08%
Tax
-85.77
71.00
-156.77
-220.80%
Provisions and contingencies
0
0
0.00
Profit After Tax
136.09
-58.00
194.09
334.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
136.09
-58.00
194.09
334.64%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
136.09
-58.00
194.09
334.64%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
781.16
6,448.00
-5,666.84
-87.89%
Earnings per share (EPS)
4.65
-0.16
4.81
3,006.25%
Diluted Earnings per share
4.65
-0.16
4.81
3,006.25%
Operating Profit Margin (Excl OI)
17.14%
11.25%
0.00
5.89%
Gross Profit Margin
20.12%
7.97%
0.00
12.15%
PAT Margin
50.58%
-4.13%
0.00
54.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.91 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 19.87% vs 3.41% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 12.27% vs 24.52% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.61 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 1,274.75% vs 375.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 286.65% vs 137.84% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.99 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 275.19% vs 13,200.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 45.06% vs 240.59% in Dec 2024

Quarterly - Interest
Interest 0.01 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.14%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024